Company intelligence / Profile preview
EcuaBIRM
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
EcuaBIRM is an Ecuadorian biotechnology company dedicated to the development and commercialization of BIRM (Biological Immune Response Modulator). Founded by Dr. Edwin Cevallos, the company produces a proprietary, non-toxic plant extract designed to balance and strengthen the immune system. BIRM is used globally as an adjuvant treatment for complex pathologies such as cancer, HIV, and various autoimmune conditions. The company's products are available in several formulations, including oral concentrates and capsules, and are backed by decades of clinical observation and research in Ecuador. EcuaBIRM continues to expand its international presence, positioning its flagship product as a natural immunomodulator with high safety profiles.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on EcuaBIRM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EcuaBIRM.